Search Results - "Larrayoz, Marta"

Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.

Authors: Muiños-Lopez, Emma Lopez-Perez, Ana Rosa Sudupe, Laura et al.

Source: Communications Biology. 11/20/2025, Vol. 8 Issue 1, p1-15. 15p.

VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A.

Authors: Catena, Raúl Larzabal, Leyre Larrayoz, Marta et al.

Source: Molecular Cancer. 2010, Vol. 9, p320-333. 14p.

The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eμm-TCL1 mouse model.

Authors: Blunt, Matthew D. Carter, Matthew J. Larrayoz, Marta et al.

Source: Blood. 6/25/2015, Vol. 125 Issue 26, p4032-4041. 10p.

Preneoplastic somatic mutations including MYD88^L265P in lymphoplasmacytic lymphoma.

Authors: Rodriguez, Sara Celay, Jon Goicoechea, Ibai et al.

Source: Science Advances. 1/21/2022, Vol. 8 Issue 3, p1-18. 18p.

Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.

Authors: D'Avola, Annalisa Drennan, Samantha Tracy, Ian et al.

Source: Blood. 8/11/2016, Vol. 128 Issue 6, p816-826. 11p.

IL-4 enhances expression and function of surface IgM in CLL cells.

Authors: Aguilar-Hernandez, Maria M. Blunt, Matthew D. Dobson, Rachel et al.

Source: Blood. 6/16/2016, Vol. 127 Issue 24, p3015-3025. 11p.

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

Authors: Gonzalez C Guerrero C Larrayoz M et al.

Source: Blood [Blood] 2026 Jul 24. Date of Electronic Publication: 2026 Jul 24.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

Authors: Hu B Edwards J Modi H et al.

Source: Blood [Blood] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Authors: Cenzano I Cócera M Larrayoz M et al.

Source: Nature communications [Nat Commun] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

Authors: Schavgoulidze A Cui J Encinas J et al.

Source: Blood [Blood] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Authors: Chen LY Aleman A Larrayoz M et al.

Source: Blood [Blood] 2026 May 08. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Authors: Celay J Recalde M Revuelta MV et al.

Source: Molecular cancer [Mol Cancer] 2026 Apr 20. Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.

Authors: Jelinek T Zihala D Zabaleta A et al.

Source: Blood [Blood] 2026 Mar 05; Vol. 147 (10), pp. 1070-1082.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Authors: Navarro F Lozano T Fuentes-García A et al.

Source: Blood [Blood] 2025 Dec 11; Vol. 146 (24), pp. 2931-2944.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma.

Authors: Bjorklund CC Larrayoz M Kang J et al.

Source: Blood neoplasia [Blood Neoplasia] 2025 Nov 07; Vol. 3 (1), pp. 100179. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.

Authors: Botta C Perez C Larrayoz M et al.

Corporate Authors: Botta C Perez C Larrayoz M et al.

Source: Nature communications [Nat Commun] 2023 Sep 20; Vol. 14 (1), pp. 5825. Date of Electronic Publication: 2023 Sep 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Phosphatidylserine as a tumor target for CAR-T cell therapy.

Authors: Martín-Otal C Sánchez-Moreno I Gómez-Morón A et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 23; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells.

Authors: Staudt S Nikolka F Perl M et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Feb 04. Date of Electronic Publication: 2025 Feb 04.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Authors: Larrayoz M Garcia-Barchino MJ Celay J et al.

Source: Nature medicine [Nat Med] 2023 Mar; Vol. 29 (3), pp. 632-645. Date of Electronic Publication: 2023 Mar 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.

Authors: García-Barchino MJ Sarasquete ME Panizo C et al.

Source: The Journal of pathology [J Pathol] 2018 May; Vol. 245 (1), pp. 61-73. Date of Electronic Publication: 2018 Mar 30.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE